Terms: = Thyroid cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras
352 results:
1.
Sfreddo HJ; Koh ES; Zhao K; Swartzwelder CE; Untch BR; Marti JL; Roman BR; Dublin J; Wang RS; Xia R; Cohen JM; Xu B; Ghossein R; Givi B; Boyle JO; Tuttle RM; Fagin JA; Wong RJ; Morris LGT
Thyroid; 2024 Apr; 34(4):450-459. PubMed ID: 38407967
[No Abstract] [Full Text] [Related]
2. Identification of Germline
Pires C; Saramago A; Moura MM; Li J; Donato S; Marques IJ; Belo H; Machado AC; Cabrera R; Grünewald TGP; Leite V; Cavaco BM
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396644
[TBL] [Abstract] [Full Text] [Related]
3. thyroid dysfunction caused by exposure to environmental endocrine disruptors and the underlying mechanism: A review.
He J; Xu J; Zheng M; Pan K; Yang L; Ma L; Wang C; Yu J
Chem Biol Interact; 2024 Mar; 391():110909. PubMed ID: 38340975
[TBL] [Abstract] [Full Text] [Related]
4. The Role of 5-Hydroxymethylcytosine as a Potential Epigenetic Biomarker in a Large Series of thyroid Neoplasms.
Canberk S; Gonçalves J; Rios E; Povoa AA; Tastekin E; Sobrinho-Simões M; Uguz A; Aydin O; Ince U; Soares P; Máximo V
Endocr Pathol; 2024 Mar; 35(1):25-39. PubMed ID: 38285158
[TBL] [Abstract] [Full Text] [Related]
5. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
6. Fine-needle biopsy of thyroid nodules and the contribution of molecular analysis of BRAF and RAS mutations.
Kasko M; Grigerova M; Alemayehu A; Zavodna K; Kasko V; Podoba J
Bratisl Lek Listy; 2023; 124(12):869-872. PubMed ID: 37983279
[TBL] [Abstract] [Full Text] [Related]
7. Macrofollicular Architecture in Invasive Encapsulated Follicular Variant of Papillary thyroid Carcinoma: A Pitfall in thyroid Practice.
Yadav S; Kandasamy D; Damle N; Goel R; Chumber S; Sharma MC; Boruah M; Agarwal S
Head Neck Pathol; 2023 Dec; 17(4):899-909. PubMed ID: 37775618
[TBL] [Abstract] [Full Text] [Related]
8. The histologic outcomes of indeterminate thyroid nodules with rat sarcoma mutations: A case series.
Jones M; Abendano DG; Turner M; Sullivan C; Reyes MCD
Diagn Cytopathol; 2023 Dec; 51(12):E332-E337. PubMed ID: 37583345
[TBL] [Abstract] [Full Text] [Related]
9. Non-hyalinizing trabecular thyroid adenoma: a novel thyroid tumor with diagnostic pitfalls of hyalinizing trabecular adenoma and medullary thyroid carcinoma.
Hirokawa M; Matsuse M; Mitsutake N; Suzuki A; Higuchi M; Hayashi T; Kamma H; Miyauchi A; Akamizu T
Diagn Pathol; 2023 Jun; 18(1):74. PubMed ID: 37340328
[TBL] [Abstract] [Full Text] [Related]
10. A Shift in Molecular Drivers of Papillary thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases.
Hang JF; Chen JY; Kuo PC; Lai HF; Lee TL; Tai SK; Kuo CS; Chen HS; Li WS; Li CF
Mod Pathol; 2023 Sep; 36(9):100242. PubMed ID: 37307878
[TBL] [Abstract] [Full Text] [Related]
11.
Alamri AM; Alkhilaiwi FA; Khan NU; Tasleem M
Anticancer Agents Med Chem; 2023; 23(19):2111-2126. PubMed ID: 37287303
[TBL] [Abstract] [Full Text] [Related]
12. Identification of crucial genes involved in thyroid cancer development.
Kalarani IB; Sivamani G; Veerabathiran R
J Egypt Natl Canc Inst; 2023 May; 35(1):15. PubMed ID: 37211566
[TBL] [Abstract] [Full Text] [Related]
13. Novel Susceptibility Genes Drive Familial Non-Medullary thyroid cancer in a Large Consanguineous Kindred.
Majdalani P; Yoel U; Nasasra T; Fraenkel M; Haim A; Loewenthal N; Zarivach R; Hershkovitz E; Parvari R
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175943
[TBL] [Abstract] [Full Text] [Related]
14. PD-L1 expression in rare and aggressive thyroid cancers: A preliminary investigation for a role of immunotherapy.
Boruah M; Gaddam P; Agarwal S; Mir RA; Gupta R; Sharma MC; S Deo SV; Nilima N
J Cancer Res Ther; 2023; 19(2):312-320. PubMed ID: 37006068
[TBL] [Abstract] [Full Text] [Related]
15. Molecular Genetics of Diffuse Sclerosing Papillary thyroid cancer.
Alswailem M; Alghamdi B; Alotaibi A; Aljomiah A; Al-Hindi H; Murugan AK; Abouelhoda M; Shi Y; Alzahrani AS
J Clin Endocrinol Metab; 2023 Aug; 108(9):e704-e711. PubMed ID: 36995892
[TBL] [Abstract] [Full Text] [Related]
16. Tumor-Infiltrating Immune Cell Landscapes in the Lymph Node Metastasis of Papillary thyroid cancer.
Amanullah M; Pan M; Lu K; Pan X; Lu Y; Luo D; Liu P
Curr Oncol; 2023 Feb; 30(3):2625-2641. PubMed ID: 36975413
[TBL] [Abstract] [Full Text] [Related]
17. Challenges and Strategies to Combat Resistance Mechanisms in thyroid cancer Therapeutics.
Gild ML; Bullock M; Tsang V; Clifton-Bligh RJ; Robinson BG; Wirth LJ
Thyroid; 2023 Jun; 33(6):682-690. PubMed ID: 36924302
[No Abstract] [Full Text] [Related]
18. Detection of driver mutations in plasma cell-free nucleic acids in differentiated thyroid neoplasm.
Dutta S; Tarafdar S; Mukhopadhyay P; Bhattacharyya NP; Ghosh S
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36744987
[TBL] [Abstract] [Full Text] [Related]
19. Real-life utility of five-gene panel test in preoperative thyroid fine-needle aspiration biopsy: a large cohort of 740 patients study.
Tang J; Ma J; Xi X; Wang L; Li H; Huo S; Zhang B
Endocrine; 2023 Jun; 80(3):552-562. PubMed ID: 36542267
[TBL] [Abstract] [Full Text] [Related]
20. Identification of potential inhibitor targeting KRAS mutation in Papillary thyroid Carcinoma through molecular docking and dynamic simulation analysis.
Tayubi IA; Madar IH
Comput Biol Med; 2023 Jan; 152():106377. PubMed ID: 36493736
[TBL] [Abstract] [Full Text] [Related]
[Next]